002332 仙琚制药
已收盘 09-07 15:00:00
资讯
新帖
简况
股市必读:仙琚制药(002332)股东户数4.5万户,较上期减少2.17%
证券之星 · 09-07 01:44
股市必读:仙琚制药(002332)股东户数4.5万户,较上期减少2.17%
仙琚制药(002332)9月3日股东户数4.5万户,较上期减少2.17%
证券之星 · 09-04
仙琚制药(002332)9月3日股东户数4.5万户,较上期减少2.17%
仙琚制药:截止近期,公司股东约4万5千户
证券之星 · 09-04
仙琚制药:截止近期,公司股东约4万5千户
仙琚制药(002332.SZ):黄体酮阴道片获得美国FDA注册申请受理
智通财经 · 09-01
仙琚制药(002332.SZ):黄体酮阴道片获得美国FDA注册申请受理
股市必读:仙琚制药中报 - 第二季度单季净利润同比下降8.29%
证券之星 · 08-31
股市必读:仙琚制药中报 - 第二季度单季净利润同比下降8.29%
仙琚制药(002332)披露《董事会秘书工作细则》,8月28日股价上涨1.16%
证券之星 · 08-28
仙琚制药(002332)披露《董事会秘书工作细则》,8月28日股价上涨1.16%
仙琚制药(002332)7月20日股东户数4.6万户,较上期增加2.03%
证券之星 · 08-28
仙琚制药(002332)7月20日股东户数4.6万户,较上期增加2.03%
图解仙琚制药中报:第二季度单季净利润同比下降8.29%
证券之星 · 08-28
图解仙琚制药中报:第二季度单季净利润同比下降8.29%
仙琚制药拟每10股派发现金红利1元
财中社 · 08-27
仙琚制药拟每10股派发现金红利1元
仙琚制药:截止近期,公司股东约4万6千户
证券之星 · 08-25
仙琚制药:截止近期,公司股东约4万6千户
股市必读:仙琚制药(002332)8月20日董秘有最新回复
证券之星 · 08-21
股市必读:仙琚制药(002332)8月20日董秘有最新回复
仙琚制药:阿更葡糖钠注射液处于上市销售前的符合性检查阶段
证券之星 · 08-20
仙琚制药:阿更葡糖钠注射液处于上市销售前的符合性检查阶段
股市必读:仙琚制药(002332)8月12日董秘有最新回复
证券之星 · 08-13
股市必读:仙琚制药(002332)8月12日董秘有最新回复
仙琚制药:截止近期,公司股东约4万6千户
证券之星 · 08-12
仙琚制药:截止近期,公司股东约4万6千户
股市必读:仙琚制药新发布《关于子公司签署和解协议并收到和解款项的公告》
证券之星 · 08-12
股市必读:仙琚制药新发布《关于子公司签署和解协议并收到和解款项的公告》
仙琚制药(002332)披露子公司签署和解协议并收到和解款项公告,8月10日股价上涨0.35%
证券之星 · 08-10
仙琚制药(002332)披露子公司签署和解协议并收到和解款项公告,8月10日股价上涨0.35%
仙琚制药最新公告:子公司签署和解协议并收到1000万欧元和解款
证券之星 · 08-10
仙琚制药最新公告:子公司签署和解协议并收到1000万欧元和解款
股市必读:仙琚制药新发布《关于回购公司股份实施结果暨股份变动的公告》
证券之星 · 08-10
股市必读:仙琚制药新发布《关于回购公司股份实施结果暨股份变动的公告》
仙琚制药(002332)披露回购公司股份实施结果暨股份变动公告,8月7日股价上涨0.95%
证券之星 · 08-07
仙琚制药(002332)披露回购公司股份实施结果暨股份变动公告,8月7日股价上涨0.95%
股市必读:仙琚制药(002332)8月5日董秘有最新回复
证券之星 · 08-06
股市必读:仙琚制药(002332)8月5日董秘有最新回复
暂无数据
公司概况
公司名称:
浙江仙琚制药股份有限公司
所属行业:
医药制造业
上市日期:
2010-01-12
主营业务:
浙江仙琚制药股份有限公司的主营业务是甾体激素类原料药及制剂的研发、生产与销售。公司的主要产品是皮质激素、性激素、孕激素、甾体衍生物。公司系国家企业技术中心及国家级制造业单项冠军企业。公司在中国医药工业信息中心主办的第43届全国医药工业信息年会中荣获“2025年度中国医药工业主营业务收入百强”及“中国医药工业最具投资价值医药企业”;成功入选2026年浙江省未来工厂培育试点企业。
发行价格:
8.20
{"stockData":{"symbol":"002332","market":"SZ","secType":"STK","nameCN":"仙琚制药","latestPrice":8.64,"timestamp":1788764625000,"preClose":8.68,"halted":0,"volume":10549600,"delay":0,"changeRate":-0.0046,"floatShares":986000000,"shares":989000000,"eps":0.3902,"marketStatus":"已收盘","change":-0.04,"latestTime":"09-07 15:00:00","open":8.68,"high":8.72,"low":8.63,"amount":91457100,"amplitude":0.0104,"askPrice":8.65,"askSize":106,"bidPrice":8.64,"bidSize":673,"shortable":0,"etf":0,"ttmEps":0.3902,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788831000000},"marketStatusCode":5,"adr":0,"adjPreClose":8.68,"symbolType":"stock","openAndCloseTimeList":[[1788744600000,1788751800000],[1788757200000,1788764400000]],"highLimit":9.55,"lowLimit":7.81,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":989204866,"isCdr":false,"pbRate":1.44,"roa":"--","peRate":22.142491,"roe":"4.02%","epsLYR":0.45,"committee":0.575979,"marketValue":8547000000,"turnoverRate":0.0107,"status":1,"floatMarketCap":8517000000},"requestUrl":"/m/hq/s/002332/tweets","defaultTab":"tweets","newsList":[{"id":"2665395367","title":"股市必读:仙琚制药(002332)股东户数4.5万户,较上期减少2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665395367","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665395367?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:44","pubTimestamp":1788716652,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,仙琚制药报收于8.68元,下跌0.34%,换手率1.4%,成交量13.83万手,成交额1.2亿元。股本股东变化:截至2026年9月3日,仙琚制药股东户数为4.5万户,较8月24日减少1000户,减幅2.17%。股本股东变化股东户数变动截至2026年9月3日公司股东户数为4.5万户,较8月24日减少1000.0户,减幅为2.17%;户均持股数量由上期的2.15万股增加至2.2万股,户均持股市值为19.15万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0239","BK0028","002332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664333312","title":"仙琚制药(002332)9月3日股东户数4.5万户,较上期减少2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664333312","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664333312?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:33","pubTimestamp":1788514423,"startTime":"0","endTime":"0","summary":"证券之星消息,近日仙琚制药披露,截至2026年9月3日公司股东户数为4.5万户,较8月24日减少1000.0户,减幅为2.17%。在化学制药行业个股中,仙琚制药股东户数高于行业平均水平,截至9月3日,化学制药行业平均股东户数为3.65万户。从股价来看,2026年8月24日至2026年9月3日,仙琚制药区间涨幅为3.2%,在此期间股东户数减少1000.0户,减幅为2.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400030899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0028","BK0239","002332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664863313","title":"仙琚制药:截止近期,公司股东约4万5千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2664863313","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664863313?lang=zh_cn&edition=full","pubTime":"2026-09-04 11:37","pubTimestamp":1788493036,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药(002332)09月03日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年8月31日A股股东人数是多少?谢谢仙琚制药回复:您好,感谢您的关注!截止近期,公司股东约4万5千户。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400016728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332","SG9999014674.SGD","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664385320","title":"仙琚制药(002332.SZ):黄体酮阴道片获得美国FDA注册申请受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385320","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664385320?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:00","pubTimestamp":1788260459,"startTime":"0","endTime":"0","summary":"智通财经APP讯,仙琚制药(002332.SZ)发布公告,公司向美国食品药品监督管理局(简称“FDA”)递交了黄体酮阴道片的ANDA注册申请,公司于近日收到美国FDA注册申请受理的通知。黄体酮阴道片适应症为辅助生殖ART黄体支持,通过补充黄体功能,支持胚胎着床与早期妊娠。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LABU","BK0028","SG9999014674.SGD","BK4588","BK4585","BK0239","002332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663028661","title":"股市必读:仙琚制药中报 - 第二季度单季净利润同比下降8.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663028661","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663028661?lang=zh_cn&edition=full","pubTime":"2026-08-31 07:54","pubTimestamp":1788134052,"startTime":"0","endTime":"0","summary":"业绩披露要点:2026年中报显示归母净利润2.45亿元,同比下降20.67%;第二季度扣非净利润同比上升23.82%。其中第二季度单季度主营收入10.4亿元,同比上升20.82%;单季度归母净利润1.51亿元,同比下降8.29%;单季度扣非净利润1.52亿元,同比上升23.82%;负债率15.23%,投资收益-910.33万元,财务费用533.46万元,毛利率62.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662062709","title":"仙琚制药(002332)披露《董事会秘书工作细则》,8月28日股价上涨1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662062709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662062709?lang=zh_cn&edition=full","pubTime":"2026-08-28 19:14","pubTimestamp":1787915650,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,仙琚制药报收于8.72元,较前一交易日上涨1.16%,最新总市值为86.26亿元。该股当日开盘8.76元,最高8.78元,最低8.62元,成交额达1.29亿元,换手率为1.51%。近日,仙琚制药发布《董事会秘书工作细则》公告。公告显示,公司制定了《董事会秘书工作细则》,明确了董事会秘书的任职资格、主要职责、履职环境、任免程序及责任追究等内容。公司应为董事会秘书履职提供必要条件,确保其独立行使职权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800044724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332","BK0028","BK0239","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662066136","title":"仙琚制药(002332)7月20日股东户数4.6万户,较上期增加2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662066136","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662066136?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:47","pubTimestamp":1787910455,"startTime":"0","endTime":"0","summary":"证券之星消息,近日仙琚制药披露,截至2026年7月20日公司股东户数为4.6万户,较6月30日增加915.0户,增幅为2.03%。在化学制药行业个股中,仙琚制药股东户数高于行业平均水平,截至7月20日,化学制药行业平均股东户数为3.67万户。从股价来看,2026年6月30日至2026年7月20日,仙琚制药区间涨幅为6.95%,在此期间股东户数增加915.0户,增幅为2.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800041136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002332","SG9999014674.SGD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080495","title":"图解仙琚制药中报:第二季度单季净利润同比下降8.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080495","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662080495?lang=zh_cn&edition=full","pubTime":"2026-08-28 03:40","pubTimestamp":1787859625,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药2026年中报显示,上半年度公司主营收入19.59亿元,同比上升4.78%;归母净利润2.45亿元,同比下降20.67%;扣非净利润2.42亿元,同比下降9.31%;其中2026年第二季度,公司单季度主营收入10.4亿元,同比上升20.82%;单季度归母净利润1.51亿元,同比下降8.29%;单季度扣非净利润1.52亿元,同比上升23.82%;负债率15.23%,投资收益-910.33万元,财务费用533.46万元,毛利率62.15%。财报数据概要请见下图:本文数据来源于仙琚制药2026年中报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800006906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662608816","title":"仙琚制药拟每10股派发现金红利1元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662608816","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662608816?lang=zh_cn&edition=full","pubTime":"2026-08-27 21:04","pubTimestamp":1787835840,"startTime":"0","endTime":"0","summary":"8月27日,仙琚制药(002332)发布公告,公司拟向全体股东每10股派发现金红利1元(含税),预计总派发金额为9713万元。2026年中期,仙琚制药实现收入19.59亿元,归母净利润2.45亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2026-08-27/doc-inipuiyp9156385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","SG9999014674.SGD","002332","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662202634","title":"仙琚制药:截止近期,公司股东约4万6千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2662202634","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662202634?lang=zh_cn&edition=full","pubTime":"2026-08-25 08:27","pubTimestamp":1787617627,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药(002332)08月24日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年8月20日A股股东人数是多少?谢谢仙琚制药回复:您好,感谢您的关注!截止近期,公司股东约4万6千户。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500012546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002332","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661231251","title":"股市必读:仙琚制药(002332)8月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2661231251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661231251?lang=zh_cn&edition=full","pubTime":"2026-08-21 02:55","pubTimestamp":1787252112,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘,仙琚制药报收于8.61元,上涨1.65%,换手率1.54%,成交量15.14万手,成交额1.3亿元。董秘最新回复投资者: 尊敬的董秘:请问咱公司的奥美克松钠投入生产了吗?据了解,阿更葡糖钠注射液处于上市销售前的符合性检查阶段,预计2026年4季度商业化销售。公司高端制剂项目部分产品正在申报审批阶段。当日关注点交易信息汇总:8月20日主力资金净流出333.57万元,游资资金净流出624.17万元,散户资金净流入957.74万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100002089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332","BK0028","BK0239","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660026264","title":"仙琚制药:阿更葡糖钠注射液处于上市销售前的符合性检查阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2660026264","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660026264?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:30","pubTimestamp":1787214627,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药08月20日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,关注到公司高端制剂募资项目土建已完成,设备安装调试基本结束,同时阿更葡糖钠注射液已于今年7月获批上市,请问:1.高端制剂项目预计何时完成工艺验证并正式投产?据了解,阿更葡糖钠注射液处于上市销售前的符合性检查阶段,谢谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000028697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002332","BK0239","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659904553","title":"股市必读:仙琚制药(002332)8月12日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2659904553","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659904553?lang=zh_cn&edition=full","pubTime":"2026-08-13 01:42","pubTimestamp":1786556537,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘,仙琚制药报收于8.58元,上涨0.7%,换手率1.21%,成交量11.95万手,成交额1.03亿元。董秘最新回复投资者: 尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年8月10日A股股东人数是多少?截止近期,公司股东约4万6千户。当日关注点交易信息汇总:8月12日主力资金净流出356.39万元,占总成交额3.47%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300001199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","002332","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658924683","title":"仙琚制药:截止近期,公司股东约4万6千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2658924683","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658924683?lang=zh_cn&edition=full","pubTime":"2026-08-12 15:03","pubTimestamp":1786518195,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药(002332)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年8月10日A股股东人数是多少?谢谢仙琚制药回复:您好,感谢您的关注!截止近期,公司股东约4万6千户。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200020333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","002332","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912251","title":"股市必读:仙琚制药新发布《关于子公司签署和解协议并收到和解款项的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658912251?lang=zh_cn&edition=full","pubTime":"2026-08-12 01:31","pubTimestamp":1786469470,"startTime":"0","endTime":"0","summary":"公司公告汇总关于子公司签署和解协议并收到和解款项的公告浙江仙琚制药股份有限公司全资子公司Newchem S.P.A与匈牙利吉瑞大药厂及其全资子公司比利时Estetra SRL制药公司就原料药供货协议争议事项签署《和解协议》。Newchem公司因Mithra公司未履行协议义务,于2025年3月向日内瓦初审法院对Estetra公司提起诉讼。根据和解协议,Gedeon Richter公司已向Newchem公司支付和解款项1000万欧元,款项已于2026年8月7日全额到账。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200001770.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332","BK0239","BK0028","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658493783","title":"仙琚制药(002332)披露子公司签署和解协议并收到和解款项公告,8月10日股价上涨0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658493783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658493783?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:36","pubTimestamp":1786372579,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘,仙琚制药报收于8.57元,较前一交易日上涨0.35%,最新总市值为84.77亿元。近日,仙琚制药披露《关于子公司签署和解协议并收到和解款项的公告》。Newchem公司因Mithra公司未履行协议义务,于2025年3月向日内瓦初审法院对Estetra公司提起诉讼。2024年6月Mithra公司进入破产程序,Gedeon Richter公司收购Estetra公司100%股份及部分资产。根据和解协议,Gedeon Richter公司已向Newchem公司支付和解款项1000万欧元,款项已于2026年8月7日全额到账。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000034469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0028","002332","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658934532","title":"仙琚制药最新公告:子公司签署和解协议并收到1000万欧元和解款","url":"https://stock-news.laohu8.com/highlight/detail?id=2658934532","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658934532?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:42","pubTimestamp":1786369339,"startTime":"0","endTime":"0","summary":"仙琚制药(002332.SZ)公告称,公司全资子公司Newchem与匈牙利吉瑞大药厂及其子公司Estetra就原料药供货协议争议签署和解协议,GedeonRichter向Newchem支付和解款项1000万欧元。Newchem已于2026年8月7日收到全部款项,预计对公司2026年三季度非经常性损益产生一定影响。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000032942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["FXE","MEURmain","EURmain","EUO","BK0239","BK0028","002332","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658670784","title":"股市必读:仙琚制药新发布《关于回购公司股份实施结果暨股份变动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658670784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658670784?lang=zh_cn&edition=full","pubTime":"2026-08-10 01:46","pubTimestamp":1786297573,"startTime":"0","endTime":"0","summary":"公司公告汇总关于回购公司股份实施结果暨股份变动的公告浙江仙琚制药股份有限公司于2026年5月14日审议通过回购股份方案,拟使用自有资金及自筹资金8,000万元至15,000万元,以集中竞价交易方式回购公司股份,用于股权激励或员工持股计划,回购价格不超过13.45元/股;因实施2025年度权益分派,回购价格上限调整至13.25元/股。回购期间相关主体无买卖股票行为。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002332","BK0028","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657644620","title":"仙琚制药(002332)披露回购公司股份实施结果暨股份变动公告,8月7日股价上涨0.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644620","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657644620?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:21","pubTimestamp":1786112488,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,仙琚制药报收于8.54元,较前一交易日上涨0.95%,最新总市值为84.48亿元。该股当日开盘8.49元,最高8.55元,最低8.39元,成交额达1.05亿元,换手率为1.26%。近日,仙琚制药发布《关于回购公司股份实施结果暨股份变动的公告》。因实施2025年度权益分派,回购价格上限调整至13.25元/股。截至2026年8月8日,公司累计回购股份17,952,962股,占总股本的1.8149%,使用资金总额149,999,703.60元,回购实施完毕。回购期间相关主体无买卖股票行为,回购符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700041076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332","SG9999014674.SGD","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657529021","title":"股市必读:仙琚制药(002332)8月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657529021","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657529021?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:02","pubTimestamp":1785949340,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘,仙琚制药报收于8.6元,下跌0.92%,换手率1.13%,成交量11.08万手,成交额9545.78万元。董秘最新回复投资者: 董秘,你好!贵司药械一体化吸入软雾剂生产线,实现制剂与吸入装置完全自产,按什么标准建设?该产线建设阶段按照国内和国外双报标准设计建设。当日关注点交易信息汇总:8月5日主力资金净流入1363.07万元,占总成交额14.28%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","SG9999014674.SGD","002332"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788822642008,"stockEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":0.0117},{"period":"3month","weight":0.0524},{"period":"6month","weight":-0.0275},{"period":"1year","weight":-0.1557},{"period":"ytd","weight":-0.0177}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.0019},{"period":"3month","weight":-0.0193},{"period":"6month","weight":-0.0486},{"period":"1year","weight":0.0315},{"period":"ytd","weight":-0.0091}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江仙琚制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"45000人(较上一季度减少2.17%)","perCapita":"21904股","listingDate":"2010-01-12","address":"浙江省台州市仙居县仙药路1号","registeredCapital":"98920万元","survey":" 浙江仙琚制药股份有限公司的主营业务是甾体激素类原料药及制剂的研发、生产与销售。公司的主要产品是皮质激素、性激素、孕激素、甾体衍生物。公司系国家企业技术中心及国家级制造业单项冠军企业。公司在中国医药工业信息中心主办的第43届全国医药工业信息年会中荣获“2025年度中国医药工业主营业务收入百强”及“中国医药工业最具投资价值医药企业”;成功入选2026年浙江省未来工厂培育试点企业。","listedPrice":8.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仙琚制药(002332)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仙琚制药(002332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仙琚制药,002332,仙琚制药股票,仙琚制药股票老虎,仙琚制药股票老虎国际,仙琚制药行情,仙琚制药股票行情,仙琚制药股价,仙琚制药股市,仙琚制药股票价格,仙琚制药股票交易,仙琚制药股票购买,仙琚制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仙琚制药(002332)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仙琚制药(002332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}